[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HUP0104872A3 - New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use - Google Patents

New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use

Info

Publication number
HUP0104872A3
HUP0104872A3 HU0104872A HUP0104872A HUP0104872A3 HU P0104872 A3 HUP0104872 A3 HU P0104872A3 HU 0104872 A HU0104872 A HU 0104872A HU P0104872 A HUP0104872 A HU P0104872A HU P0104872 A3 HUP0104872 A3 HU P0104872A3
Authority
HU
Hungary
Prior art keywords
venlafaxine
preparation
pharmaceutical compositions
compositions containing
polymorphic forms
Prior art date
Application number
HU0104872A
Other languages
Hungarian (hu)
Original Assignee
Egis Gyogyszergyar Nyilvanosan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan filed Critical Egis Gyogyszergyar Nyilvanosan
Priority to HU0104872A priority Critical patent/HUP0104872A3/en
Publication of HU0104872D0 publication Critical patent/HU0104872D0/en
Priority to PCT/HU2002/000121 priority patent/WO2003042161A1/en
Publication of HUP0104872A2 publication Critical patent/HUP0104872A2/en
Publication of HUP0104872A3 publication Critical patent/HUP0104872A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0104872A 2001-11-13 2001-11-13 New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use HUP0104872A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU0104872A HUP0104872A3 (en) 2001-11-13 2001-11-13 New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
PCT/HU2002/000121 WO2003042161A1 (en) 2001-11-13 2002-11-13 Venlafaxine hydrochloride polymorphs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0104872A HUP0104872A3 (en) 2001-11-13 2001-11-13 New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use

Publications (3)

Publication Number Publication Date
HU0104872D0 HU0104872D0 (en) 2002-01-28
HUP0104872A2 HUP0104872A2 (en) 2003-08-28
HUP0104872A3 true HUP0104872A3 (en) 2004-04-28

Family

ID=89979881

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104872A HUP0104872A3 (en) 2001-11-13 2001-11-13 New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use

Country Status (2)

Country Link
HU (1) HUP0104872A3 (en)
WO (1) WO2003042161A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE57198A1 (en) * 1996-03-25 1998-10-10 American Home Prod PROLONGED RELEASE FORMULA
AU2002241764A1 (en) * 2000-10-19 2002-06-18 Teva Pharmaceutical Industries Ltd. Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU1234002A (en) * 2000-10-31 2002-05-15 Ciba Sc Holding Ag Crystalline forms of venlafaxine hydrochloride
AU2001235970A1 (en) * 2000-12-07 2002-06-18 Dr. Reddy's Research Foundation Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
WO2003042161A1 (en) 2003-05-22
HU0104872D0 (en) 2002-01-28
HUP0104872A2 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
HUP0303128A3 (en) Novel succinate salt of o-desmethyl-venlafaxine, process for preparation thereof, its use and pharmaceutical composition containing it
HUP0401619A3 (en) Phenethanolamine derivatives, process for their preparation and pharmaceutical composition containing them
HUP0302656A3 (en) Fumaric acid amides, their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing the compounds
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
HUP0401537A3 (en) Thiohydantoins, process for their preparation, pharmaceutical compositions containing them and use thereof for preparation of pharmaceutical compositions
HUP0402063A3 (en) Indole-2-carboxamides process for producing them, pharmaceutical compositions containing them and use thereof
HUP0400998A3 (en) Novel compounds of anti-inflammatory, immunomodulatory and anti-proliferatory effect, process for their preparation and pharmaceutical compositions containing them
HUP0402225A3 (en) Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them
HUP0401241A3 (en) Novel cyclohexyl sulphones, process for their preparation and pharmaceutical compositions containing them
HUP0301069A3 (en) Novel biarylcarboxamides, process for their preparation, pharmaceutical compositions containing them and their use
HUP0103988A3 (en) N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfonamides, process for their preparation, their use and pharmaceutical compositions containing them
HUP0203559A3 (en) Polymorphic forms of sertraline hydrochloride, process for their preparation and pharmaceutical compositions containing them
IL161693A0 (en) N-adamantylmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation
HUP0401141A3 (en) Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP0400208A3 (en) N-formyl hydroxylamine compounds, process for their preparation and pharmaceutical compositions containing them
HUP0400040A2 (en) Sulfonamides, process for their preparation and pharmaceutical compositions containing them
HUP0303813A3 (en) Arylsulfonamides as antiviral agents, process for preparation of the compounds and pharmaceutical compositions containing them
HUP0400350A3 (en) Novel cyano-substituted dihydropyrimidine compounds, process for producing them, their use and pharmaceutical compositions containing them
HUP0100489A3 (en) New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0401082A3 (en) Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them
AU2003231920A8 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
HUP0401829A3 (en) Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- or 4-heteroarylcyclohexane compounds, process for their preparation and pharmaceutical compositions containing the (1h)-quinoxalin-2-one compounds
IL159448A0 (en) Process for preparation of cyclohexanol derivatives
HUP0201024A3 (en) Izoindeindolone compounds, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: EGIS GYOGYSZERGYAR NYILVANOSAN MUEKOEDOE RESZV, HU

Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR RT., HU

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished